Laddar...

Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease

Monoclonal antibodies to tumor necrosis factor (TNF) have become a mainstay of the therapeutic armamentarium in inflammatory bowel disease (IBD) over the last 15 years. Although highly effective, primary and secondary nonresponse are common and associated with poor clinical outcomes and significant...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Therap Adv Gastroenterol
Huvudupphovsmän: Kopylov, Uri, Seidman, Ernest
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2016
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4913332/
https://ncbi.nlm.nih.gov/pubmed/27366220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16638833
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!